Oncobiologics is a privately held company funded through Series A investments from a diverse range of sources, including:
1) US Government Grant
2) Executives from the Pharmaceutical Industry
3) Small Business Administration Financing
4) Strategic Partners
5) Employees, Friends and Family
The company has achieved early revenue milestones and is now largely self-sustaining through revenue. The Series A investment round is being extended to further accelerate the company’s growth. As a result, Oncobiologics is currently seeking investors. Series A terms have been crafted to limit investment risk, while providing significant potential for growth.
The Oncobiologics team is passionate about seeking cures for serious diseases and we seek investment partners who share that interest.
For additional information, please contact email@example.com